Search Results 401-410 of 16870 for Antagonist
Preclinical studies in drug therapies for polycystic kidney disease, such as octreotide and vasopressin antagonists. Finding effective therapies for ...
Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...
Exposure to more than 1 TNF-antagonist or primary failure to TNF antagonist therapy; History of or current chronic or recurrent infections; Subjects with ...
Patients must have received no more than 28 weeks of SST, as measured from the date of first hormonal therapy (LHRH agonist or LHRH antagonist) or surgical ...
angiotensin II receptor antagonist (ARB) within 0-24 weeks prior to enrollment. - Glomerular filtration rate ≤ 30 ml/min (for both male and female ...
luteinizing hormone-releasing hormone agonists or antagonists ... Untreated or poorly controlled, gastro-esophageal reflux disease. 19. Have taken histamine-H2 ...
JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.